Oncodesign Services
Drug discovery and preclinical CRO specializing in oncology, inflammation, and infectious diseases.
Listed on cro.directory
Contract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995. Headquartered in Dijon, France.
Phases
Indications / Therapeutic Areas
Services
- Discovery Research
- Target Identification & Validation
- Medicinal Chemistry
- In Vitro Pharmacology
- In Vitro ADME / DMPK
- In Vivo PK / PD Studies
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- Specialized & Large-Animal Models
- Bioanalysis
- Immunogenicity Assays (ADA / NAb)
- Biomarker Assays
- Clinical Imaging Core Lab
- Oncology Specialty Services
- Immunology & Inflammation Services
- Virology Services
- GLP Toxicology
- Safety Pharmacology
- Translational Research
- Preclinical In Vitro Studies
- Regulatory Affairs
- LC-MS Bioanalysis (Small Molecule)
- High-Throughput Screening
- Genetic Toxicology
- Computational & In-Silico Drug Discovery
- Carcinogenicity Studies
- DART (Reproductive & Developmental Toxicology)
- Flow Cytometry Services
- Analytical Method Development & Validation
- ICH Stability Studies
- Ligand-Binding Bioanalysis (Large Molecule)
Modalities
Technical specifications & accreditations
Accreditations
Infrastructure
About this organization
Overview
Oncodesign Services is a contract research organization (CRO) dedicated to drug discovery and preclinical research. Founded in 1995, the organization has pioneered translational sciences and pharmacology for over 25 years, working to establish a technological continuum from therapeutic target identification through to patient qualification of efficacy for new treatments.
Therapeutic Areas
The company specializes in:
- Oncology: Translational pharmacology and cancer research
- Inflammation: Preclinical inflammatory and autoimmune models covering skin, gut, lungs, kidneys, liver, and related diseases
- Infectious Diseases: Drug discovery services
Service Offerings
Oncodesign Services provides comprehensive drug discovery and preclinical support across multiple development stages:
- Target Stage: Drive-IDDS platform supporting small molecule (including PROTAC), Molecular RadioTherapy (MRT), and biologics discovery
- Drug Candidate Stage: Solo platform with POC oncology, POC inflammation, pharmaco-imaging & MRT, DMPK–bioanalysis, and microbiome services
- IND Stage: D-vlop platform including toxicology, CMC, and clinical protocol support
Organization
The company operates 3 sites and employs approximately 230 people, including 22% with PhD qualifications. The organization has served approximately 1,000 clients and maintains core values of solidarity, ingenuity, vitality, rational approach, and integrity.
Locations
Headquarters
Dijon · Bourgogne-Franche-Comté · France
Headquarters
Submit a verified review for this organization.
Markdown mirror: /companies/oncodesign-services.md